BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 37197843)

  • 1. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
    Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
    J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
    Marnell CS; Bick A; Natarajan P
    J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
    Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE;
    Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
    Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
    JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
    Yu B; Roberts MB; Raffield LM; Zekavat SM; Nguyen NQH; Biggs ML; Brown MR; Griffin G; Desai P; Correa A; Morrison AC; Shah AM; Niroula A; Uddin MM; Honigberg MC; Ebert BL; Psaty BM; Whitsel EA; Manson JE; Kooperberg C; Bick AG; Ballantyne CM; Reiner AP; Natarajan P; Eaton CB;
    J Am Coll Cardiol; 2021 Jul; 78(1):42-52. PubMed ID: 34210413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
    Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
    JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood.
    Schuermans A; Nakao T; Ruan Y; Koyama S; Yu Z; Uddin MM; Haidermota S; Hornsby W; Lewandowski AJ; Bick AG; Niroula A; Jaiswal S; Ebert BL; Natarajan P; Honigberg MC
    J Am Heart Assoc; 2023 Jul; 12(13):e030220. PubMed ID: 37345823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis.
    Bick AG; Pirruccello JP; Griffin GK; Gupta N; Gabriel S; Saleheen D; Libby P; Kathiresan S; Natarajan P
    Circulation; 2020 Jan; 141(2):124-131. PubMed ID: 31707836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
    Jaiswal S; Natarajan P; Silver AJ; Gibson CJ; Bick AG; Shvartz E; McConkey M; Gupta N; Gabriel S; Ardissino D; Baber U; Mehran R; Fuster V; Danesh J; Frossard P; Saleheen D; Melander O; Sukhova GK; Neuberg D; Libby P; Kathiresan S; Ebert BL
    N Engl J Med; 2017 Jul; 377(2):111-121. PubMed ID: 28636844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events.
    Bhattacharya R; Zekavat SM; Uddin MM; Pirruccello J; Niroula A; Gibson C; Griffin GK; Libby P; Ebert BL; Bick A; Natarajan P
    JAMA Cardiol; 2021 Sep; 6(9):1069-1077. PubMed ID: 34106216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
    Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
    JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
    Haring B; Wissel S; Manson JE
    Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.
    Yu Z; Fidler TP; Ruan Y; Vlasschaert C; Nakao T; Uddin MM; Mack T; Niroula A; Heimlich JB; Zekavat SM; Gibson CJ; Griffin GK; Wang Y; Peloso GM; Heard-Costa N; Levy D; Vasan RS; Aguet F; Ardlie KG; Taylor KD; Rich SS; Rotter JI; Libby P; Jaiswal S; Ebert BL; Bick AG; Tall AR; Natarajan P
    J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37498674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
    J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal hematopoiesis of indeterminate potential in patients with acute coronary syndrome undergoing percutaneous coronary intervention in the absence of traditional risk factors.
    Jiang Z; Li Y; Yan C; Zhang X; Zhang Q; Li J; Tian X; Qiu M; Liang Z; Ma S; Na K; Li Z; Chen S; Zhao Y; Qi Z; Liu X; Han Y
    Clin Res Cardiol; 2023 Apr; 112(4):506-517. PubMed ID: 35704087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.
    Cobo I; Tanaka T; Glass CK; Yeang C
    Curr Opin Hematol; 2022 Jan; 29(1):1-7. PubMed ID: 34654019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women.
    Honigberg MC; Zekavat SM; Niroula A; Griffin GK; Bick AG; Pirruccello JP; Nakao T; Whitsel EA; Farland LV; Laurie C; Kooperberg C; Manson JE; Gabriel S; Libby P; Reiner AP; Ebert BL; ; Natarajan P
    Circulation; 2021 Feb; 143(5):410-423. PubMed ID: 33161765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
    Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
    J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clonal hematopoiesis in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
    Makishima H
    Rinsho Ketsueki; 2022; 63(9):1042-1045. PubMed ID: 36198527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.